Your browser's JavaScript is disabled.

To properly view the content on this page, please enable JavaScript.

Publications

EHA 2021

All Publications

Efficacy of Imetelstat is Independent of Molecular Subtypes in Heavily Transfused Non-Del(5q) Lower Risk MDS (LR-MDS) Relapsed/Refractory (R/R) to Erythropoiesis Stimulating Agents (ESA)

Clinical Imetelstat: MDS Imetelstat

Platzbecker, et al.

Imetelstat Demonstrates an Acceptable Safety Profile in Myeloid Malignancies

Clinical Imetelstat: MDS Imetelstat

Mascarenhas, et al.

[facetwp facet="publication_load_more"]